Search results for "kinetics"

showing 10 items of 2224 documents

Uptake and metabolism of choline by rat brain after acute choline administration.

1992

The present study is concerned with the uptake and metabolism of choline by the rat brain. Intraperitoneal administration of choline chloride (4-60 mg/kg) caused a dose-dependent elevation of the plasma choline concentration from 11.8 to up to 165.2 microM within 10 min and the reversal of the negative arteriovenous difference (AVD) of choline across the brain to positive values at plasma choline levels of greater than 23 microM. Net choline release and uptake were linearly dependent on the plasma choline level in the physiological range of 10-50 microM, whereas the CSF choline level was significantly increased only at plasma choline levels of greater than 50 microM. The bolus injection of …

Malemedicine.medical_specialtyTime FactorsPhosphorylcholineBiologyBuffersBiochemistryCholineVeinsCellular and Molecular Neurosciencechemistry.chemical_compoundCerebrospinal fluidInternal medicinePhosphatidylcholinemedicineCholineAnimalsHomeostasisCerebrospinal FluidDose-Response Relationship DrugPhosphorylcholineOsmolar ConcentrationBrainRats Inbred StrainsMetabolismArteriesRatsDose–response relationshipKineticsEndocrinologychemistryHomeostasisCholine chlorideJournal of neurochemistry
researchProduct

Variability in individual response to various doses of omeprazole. Implications for antiulcer therapy.

1994

This study was carried out in order to perform a combined prospective assessment of the individual pharmacodynamic response and of duodenal ulcer healing in patients treated with three different doses of omeprazole. Ninety-nine patients with endoscopically proven duodenal ulcers were subdivided into three parallel groups of 33 cases, who were randomly assigned to receive orally at 0800 hr, in single blind fashion, either 10 mg, 20 mg, or 40 mg of omeprazole. All of them underwent continuous intragastric pH monitoring both in basal conditions and on the fifth day of each dose regimen; ulcer healing was then assessed endoscopically after four weeks of treatment. All three doses of omeprazole …

Malemedicine.medical_specialtyTime FactorsPhysiologymedicine.medical_treatmentGastroenterologyGastric AcidBasal (phylogenetics)PharmacokineticsInternal medicineMedicineHumansSingle-Blind MethodOmeprazoleMonitoring PhysiologicChemotherapyWound HealingDose-Response Relationship Drugbusiness.industryGastroenterologyHepatologyHydrogen-Ion ConcentrationMiddle AgedRegimenmedicine.anatomical_structurePharmacodynamicsDuodenal UlcerDuodenumFemalebusinessIon-Selective ElectrodesOmeprazolemedicine.drugDigestive diseases and sciences
researchProduct

Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

2007

The objective of this paper was to characterize the disposition phase of AM in rats, after different high doses and modalities of i.v. administration. Three fitting programs, WINNONLIN, ADAPT II and NONMEM were employed. The two-stage fitting methods led to different results, none of which can adequately explain amiodarone's behaviour, although a great amount of data per subject is available. The non-linear mixed effect modelling approach allows satisfactory estimation of population pharmacokinetic parameters, and their respective variability. The best model to define the AM pharmacokinetic profile is a two-compartment model, with saturable and dynamic plasma protein binding and linear tiss…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationAmiodaronePharmaceutical SciencePharmacologyAntiarrhythmic agentAmiodaroneModels BiologicalPharmacokineticsInternal medicineBlood plasmaAnimalsMedicineTissue DistributionDosingRats Wistareducationeducation.field_of_studyDose-Response Relationship Drugbusiness.industryBlood ProteinsBlood proteinsRatsNONMEMEndocrinologyArea Under CurveData Interpretation StatisticalInjections IntravenousbusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

Bromocriptine and Prostatic Carcinoma: Plasma Kinetics, production and Tissue Uptake of3H-Testosterone in Vivo

1978

The influence of the anti-prolactin bromocriptine on plasma kinetics, production rate and tissue uptake of testosterone was investigated in 15 patients with newly diagnosed stages C and D prostatic carcinoma. Bromocriptine was given for 5 days in a daily dose of 15 mg. orally. The studies were performed with the single injection technique using the 2-compartment model. Plasma testosterone, serum prolactin, and luteinizing and follicle-stimulating hormones were determined initially. Blood samples were drawn up to 5 hours after the injection of 3H-testosterone. For tissue studies a transrectal needle biopsy was done 3 hours post-injection. Bromocriptine suppressed prolactin and the endogenous…

Malemedicine.medical_specialtyUrologyEndogenyIn vivoInternal medicinemedicineCarcinomaHumansTestosteroneBromocriptineAgedbusiness.industryBiopsy NeedleProstatic NeoplasmsLuteinizing Hormonemedicine.diseaseBromocriptineProlactinProlactinKineticsPlasma kineticsEndocrinologyNeedle biopsyFollicle Stimulating HormonebusinessHormonemedicine.drugJournal of Urology
researchProduct

Serum concentrations of hydroxybupropion for dose optimization of depressed patients treated with bupropion.

2014

Background Bupropion is a dopamine and norepinephrine reuptake inhibitor approved for the treatment of depression and smoking cessation. According to the recently published reviews, it is a candidate for therapeutic drug monitoring (TDM) to improve therapeutic outcomes and reduce risks of intolerability or intoxication. In practice, however, the use of TDM is limited due to the chemical instability of bupropion. This investigation sought to determine if the major, active, and chemically stable metabolite 4-hydroxybupropion is a suitable measure to guide antidepressant drug therapy with bupropion. Methods 4-Hydroxybupropion serum levels were measured using a newly developed and validated hig…

Malemedicine.medical_specialtyUrologyNorepinephrine reuptake inhibitorPharmacokineticsmedicineHumansPharmacology (medical)BupropionChromatography High Pressure LiquidRetrospective StudiesPharmacologyBupropionDepressive Disordermedicine.diagnostic_testbusiness.industryTherapeutic effectHydroxybupropionMiddle AgedTherapeutic drug monitoringArea Under CurveClinical Global ImpressionAntidepressantAntidepressive Agents Second-GenerationFemalebusinessmedicine.drugHalf-LifeTherapeutic drug monitoring
researchProduct

Action of metyrapone on the redox state of free nicotinamide-adenine dinucleotide and on oxygen consumption of perfused rat livers and isolated mitoc…

1971

Metyrapone [2-methyl-1,2-bis-(3-pyridyl)-1-propanone] in a concentration of 5 mM increased the lactate/pyruvate ratio and theΒ-hydroxybutyrate/ acetoacetate ratio in the perfusion fluid of the isolated rat liver by a factor of 6 indicating a considerable shift in the ratio of free [NAD]/[NADH] in both the cytoplasmic and the mitochondrial compartment. Oxygen uptake of the isolated liver was decreased to about one half. The onset of the inhibitory effect on the respiration of the isolated organ was immediate. The inhibition lasted for at least 1 h.

Malemedicine.medical_specialtychemistry.chemical_elementHydroxybutyratesMitochondria LiverNicotinamide adenine dinucleotideIn Vitro TechniquesOxygenRedoxAcetoacetatesElectron Transportchemistry.chemical_compoundHydroxybutyrate DehydrogenaseOxygen ConsumptionInternal medicineRespirationmedicineAnimalsPyruvatesPharmacologyMetyraponeChemistryGeneral MedicineCompartment (chemistry)MetyraponeNADRatsPerfusionKineticsEndocrinologyBiochemistryLiverCytoplasmSpectrophotometryDepression ChemicalLactatesNAD+ kinasemedicine.drugFerrocyanidesPolarographyNaunyn-Schmiedebergs Archiv fur Pharmakologie
researchProduct

Effects of Joint Kinetics on Energy Cost during Repeated Vertical Jumping

2019

The present study was designed to investigate the effects of lower limb joint kinetics on energy cost during jumping.Eight male middle and long-distance runners volunteered for the study. The subjects were asked to repeat vertical jumps at a frequency of 2 Hz for 3 min on a force platform in three different surface inclination conditions: Incline (+8°), Level (0°), and Decline (-8°). Sagittal plane kinematics were obtained using a high-speed video camera. Simultaneously, ground reaction forces and EMG of the lower limb muscles were recorded. Energy cost was calculated using steady-state oxygen uptake, respiratory ratio, and vertical distance of the body.In all conditions, energy cost correl…

Malemedicine.medical_specialtyinclinationKnee JointEnergy metabolismPhysical Therapy Sports Therapy and RehabilitationPlyometric ExerciseLower limbBiomechanical Phenomena03 medical and health sciencesYoung Adult0302 clinical medicinePhysical medicine and rehabilitationOxygen ConsumptionEMGniveletstretch-shortening cyclemedicinePlyometricsHumansOrthopedics and Sports Medicineta315Joint (geology)business.industry030229 sport sciencesmechanical workVertical jumpingBiomechanical PhenomenaKineticselektromyografiaefficiencyEnergy costHip JointhyppääminenbiomekaniikkabusinessEnergy MetabolismAnkle JointMedicine and Science in Sports and Exercise
researchProduct

Nonlinearities in amoxycillin pharmacokinetics. I. Disposition studies in the rat.

1992

Several features of amoxycillin pharmacokinetics in man are not well known in spite of the extensive clinical use of the antibiotic. In this paper it is demonstrated that amoxycillin disposition kinetics in rats is clearly nonlinear, and that this may be due mainly to its elimination mechanisms. At different intravenous bolus dose levels, and in steady-state perfusion studies, the most striking feature is an increased renal clearance as dose increases (from 3.5 to 7.0 mg kg-1 for intravenous bolus, and from 4.6 to 20.0 micrograms min-1 for intravenous perfusions). This phenomenon has been attributed to a saturation of the active renal tubular reabsorption of the antibiotic. When the intrave…

Malemedicine.medical_specialtymedicine.drug_classAntibioticsPharmaceutical SciencePharmacologyModels BiologicalBolus (medicine)PharmacokineticsInternal medicinemedicineAnimalsPharmacology (medical)PharmacologyIntravenous dosePlasma clearanceAnalysis of VarianceChemistryAmoxicillinRats Inbred StrainsGeneral MedicineDispositionRatsEndocrinologyPerfusionTubular secretionBiopharmaceuticsdrug disposition
researchProduct

Dose-dependent metabolism and hepatic distribution of phenprocoumon in rats

1988

The dose-dependency of phenprocoumon disposition was determined in rats by iv administration of 0.1 and 1.0 mg/kg doses to separate groups of animals. The intrinsic clearance (unbound clearance) was 33% lower in the animals given 1.0 mg/kg dose than in the animals given 0.1 mg/kg dose. The apparent unbound volume of distribution was 55% lower and the elimination rate constant 54% higher in the high dose group than in the lower dose group. Binding of phenprocoumon to liver showed saturability with a two- to threefold higher apparent unbound fraction of phenprocoumon in liver in animals given the high dose in comparison to animals given the low dose.

Malemedicine.medical_specialtymedicine.drug_classDose dependencePhenprocoumonPharmacokineticsElimination rate constantInternal medicinemedicineAnimalsDistribution (pharmacology)Tissue DistributionPharmacology (medical)General Pharmacology Toxicology and PharmaceuticsVolume of distributionDose-Response Relationship DrugChemistryAnticoagulantRats Inbred Strains4-HydroxycoumarinsMetabolismRatsEndocrinologyLiverInjections IntravenousPhenprocoumonCarrier Proteinsmedicine.drugJournal of Pharmacokinetics and Biopharmaceutics
researchProduct

Factors responsible for interindividual differences in the dose requirement of phenprocoumon

1987

The total and unbound plasma concentrations of phenprocoumon and the prothrombin complex activity were determined in 51 patients on phenprocoumon. A 7-fold difference in the dosing rate (10-70 micrograms/kg/day) was required to maintain the prothrombin complex activity at 11-30% of normal. The variation in dosing requirement was mainly due to interindividual differences in the intrinsic clearance of phenprocoumon and only to a minor degree to differences in sensitivity to it. On average patients with myocardial infarction required only 2/3 of the daily dose of phenprocoumon of post cardiac surgery patients and patients with thrombosis and emboli. That difference appeared to be due to higher…

Malemedicine.medical_specialtymedicine.drug_classIndividualityPhenprocoumonPharmacokineticsInternal medicinemedicineHumansPharmacology (medical)Myocardial infarctionDosingPharmacologyChemistryCoronary ThrombosisAnticoagulant4-HydroxycoumarinsGeneral MedicineMiddle Agedmedicine.diseaseThrombosisCardiac surgeryEndocrinologyPhenprocoumonProthrombin TimeCardiologyFemaleProtein Bindingmedicine.drugSurgical patientsEuropean Journal of Clinical Pharmacology
researchProduct